2020 global pharmaceutical companies TOP50 list, Roche for the first time, 4 Chinese pharmaceutical companies selected

Guide: 2020 Global Pharmaceutical Company TOP50 List, Yunnan White Pharmaceuticals, China Biopharmaceuticals, Jiangsu Hengrui Pharmaceuticals and Shanghai Pharma on the listU.Slocal time, June 12, 2020, the U.SPharmaceutical Managers magazine (PharmExec) released the 2020 global pharmaceutical company TOP50 list, according to the most recent full-year drug revenue statistics, COVID has little financial impact in the latest ranking of the 50 pharmaceutical companiesThe top 10 drug companies, however, did experience the biggest personnel change in years, partly as a result of two large-scale mergersRoche's prescription drug sales rose 8.3 percent, up one notby, ending Pfizer's four-year dominanceAvastin, which accounts for 15 per cent of Roche's total revenue, remains Roche's biggest seller, but, like Herceptin and Lituxavirus, will face competition for biologic drugs in the coming yearsWith the emergence of subsequent strong drugs, Roche's main sales drivers include the multiple sclerosis drug Ocrevus, the hematopathic drug Hemlibra, and the cancer treatment drugs Tecentriq and PerjetaIn the top 50 pharmaceutical industries, the same company leads the way in drug revenues and research and development spending, which has been rare in recent yearsRoche, which invests $10.3bn in research and development in the pharmaceutical industry, is the only company to invest more than $10 bn in research and developmentfour other Chinese pharmaceutical companies to pped the list: 37th: Yunnan White Pharmaceutical Group; 42nd: China Biopharmaceuticals; 43rd: Jiangsu Hengrui Pharmaceuticals; and 48th: Shanghai Pharmaceuticals